A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Clinical trial NCT01218516 · COMPLETED

Trial details

NCT number: NCT01218516
Sponsor: Morphotek
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Lung

Start date: 2011-06-27
Primary completion: 2012-12-15
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.